Key Findings:  This retrospective study on the use of cannabis in inflammatory bowel disease (IBD) is found inconclusive evidence that cannabis is protective for IBD patients. It does appear to improve patient's perceptions of their well-being.
Type of Study:  Meta-analysis
Study Sample Size:  6
Study Result:  Inconclusive
Study Location(s):  United States
Year of Pub:  2022
Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabinoid (unspecified)
Phytocannabinoid Source:  Unspecified
Chemotype:  Chemotype I, Chemotype III